Skip to main content
x
About searching

Search results

  1. ASH 2023 – sense and serendipity in Dizal's Jackpot win

    ASH 2023 – sense and serendipity in Dizal's Jackpot win …

    - 12/11/2023 - 22:05

  2. ASH 2023 – a new EZ battle shapes up

    ASH 2023 – a new EZ battle shapes up …   Cross-trial comparison of EZH1/2 inhibitors at ASH 2023 Company Daiichi Sankyo Haihe … TRAE leading to death 0% 3% Source: ASH 2023.   On the face of it HH2853 looks slightly …

    - 01/10/2024 - 18:06

  3. ASH 2023 – lupus target could work in lymphoma too

    ASH 2023 – lupus target could work in lymphoma too …

    - 12/10/2023 - 22:44

  4. ASH 2023 – Bristol follows in Talvey’s slipstream

    ASH 2023 – Bristol follows in Talvey’s slipstream …

    - 12/09/2024 - 23:15

  5. ASH 2023 – Novartis sees early TIM-3 promise

    ASH 2023 – Novartis sees early TIM-3 promise …

    - 12/10/2023 - 22:45

  6. ASH 2023 – the search for a better Ayvakit

    ASH 2023 – the search for a better Ayvakit …

    - 12/15/2023 - 15:21

  7. ASH 2023 – J&J makes menin a three-horse race

    ASH 2023 – J&J makes menin a three-horse race … febrile  neutropenia Not given Source ASH 2023 ASH 2022 2 Oct 2023 event/ ASH 2023  abstract EHA 2023 Notes: *the …

    - 01/10/2024 - 17:43

  8. Sanofi’s Sarclisa gets one up on Darzalex

    … 84% with Darzalex + VRd vs 68% with VRd Late-breaker at ASH 2023 Note: all involved CD38 antibodies being …

    - 12/09/2023 - 22:21

  9. Crispr abandons first-generation Car-T projects

    … BCMA NCT04960579 in 2L MM; initial data at ASH 2023 Poseida claims several design features that it …

    - 12/08/2023 - 13:10

  10. Investors brush off Car-T scare

    … Autolus Ph1 Mcarty ** in ≥4L MM, data due at ASH 2023 Equecabtagene autoleucel IASO … Ph1 Mcarty ^^ (NCT04795882) in ≥4L MM, data due at ASH 2023 KITE-363* Gilead Ph1 ( NCT04989803 ) …

    - 12/04/2023 - 16:23